Live & Upcoming Events
Create an account
ESC Premium Access
Baroreflex activation therapy: its role in the management of heart failure and resistant hypertension
ESC CONGRESS 2017
CHF - Non pharmacological treatment
Organised by Charité Medical School, supported with an educational grant by CVRx
29 August 2017
12:45 - 13:45
in this session
Welcome and introduction - Baroreflex activation therapy: its role in the management of heart failure and resistant hypertension.
Professor S. Anker (Berlin, DE)
Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)
Why is the baroreflex a relevant target for both resistant hypertension and heart failure?
Professor A. Pathak (Monaco, MC)
Resistant hypertension: stimulating the baroreflex when drugs have failed.
Professor P. De Leeuw (Maastricht, NL)
Heart failure with reduced ejection fraction and a narrow QRS: how can baroreflex activation therapy help?
Professor C. Butter (Bernau bei Berlin, DE)
from this session
Professor Stefan Anker
Charite Campus Virchow Clinic, Berlin (Germany)
Professor Faiez Zannad
University of Lorraine, Vandoeuvre-Les-Nancy (France)
Professor Atul Pathak
The Princess Grace Hospital Centre, Monaco (Monaco)
Professor Peter W De Leeuw
, Maastricht (Netherlands (The))
Professor Christian Butter
Brandenburg Heart Center, Bernau bei Berlin (Germany)
This platform is supported by